Slowly reversible central scotoma: iatrogenic effect of hyperbaric oxygenation in the treatment of multiple sclerosis. | Canada Hyperbarics Skip to main content
Review Journal francais d'ophtalmologie 1987

Slowly reversible central scotoma: iatrogenic effect of hyperbaric oxygenation in the treatment of multiple sclerosis.

Lambrou GN, Kopferschmitt J, Jaeger A, Brini A — Journal francais d'ophtalmologie, 1987

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of a patient with multiple sclerosis who developed a rare eye side effect after hyperbaric oxygen therapy and subsequently reviewed existing literature on ocular toxicity of oxygen.

What They Found

They observed one patient with multiple sclerosis who developed an acute, bilateral, centro-caecal scotoma after hyperbaric oxygenation, which slowly resolved over several days. Their literature review indicated that hyperbaric oxygen can have ocular toxicity.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.

Study Limitations

A key limitation is that this study primarily reports on a single case and a literature review, which limits the generalizability of its findings to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Neurological
Source Pubmed
PubMed ID 3598057
Year Published 1987
Journal Journal francais d'ophtalmologie
MeSH Terms Adult; Female; Humans; Hyperbaric Oxygenation; Iatrogenic Disease; Optic Neuritis; Scotoma; Time Factors; Visual Acuity; Visual Fields

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology